Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125313462 | 12531346 | 2 | F | 20160625 | 20160704 | 20160706 | 20160712 | EXP | ES-AMGEN-ESPSL2016085449 | AMGEN | 81.00 | YR | E | F | Y | 73.00000 | KG | 20160712 | CN | ES | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125313462 | 12531346 | 1 | PS | ARANESP | DARBEPOETIN ALFA | 1 | Subcutaneous | 20 MCG, EVERY 15 DAYS,UNK | 1065505B | 103951 | 20 | UG | SOLUTION FOR INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125313462 | 12531346 | 1 | Chronic kidney disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125313462 | 12531346 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125313462 | 12531346 | Contusion | |
| 125313462 | 12531346 | Fall | |
| 125313462 | 12531346 | Haematoma |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125313462 | 12531346 | 1 | 20130715 | 0 |